Empire Financial Management Company, LLC
Source: SEC Form 13F · as of Mar 2026Empire Financial Management Company, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $50.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$50.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 12,369 | $11.4M |
| ABBVAbbVie Inc. | 29,469 | $6.4M |
| MRKMerck & Co., Inc. | 39,960 | $4.8M |
| CYRXCryoport, Inc. | 502,575 | $4.2M |
| AMGNAMGEN INC | 10,406 | $3.7M |
| JNJJOHNSON & JOHNSON | 14,831 | $3.6M |
| ABTABBOTT LABORATORIES | 24,424 | $2.5M |
| NVSNovartis AG | 15,997 | $2.4M |
| PFEPFIZER INC | 57,831 | $1.6M |
| TMBPioneer Green Farms, Inc. | 56,218 | $1.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,826 | $1.4M |
| CAHCardinal Health Inc. | 6,167 | $1.3M |
| RIGLRIGEL PHARMACEUTICALS INC | 45,445 | $1.2M |
| TLSITriSalus Life Sciences Inc. | 300,275 | $1.2M |
| AZNASTRAZENECA PLC | 6,000 | $1.2M |
| TEVATeva Pharmaceutical Industries Limited | 18,000 | $542K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,212 | $453K |
| GILDGILEAD SCIENCES, INC. | 3,000 | $418K |
| BMYBRISTOL MYERS SQUIBB CO | 6,190 | $375K |
| GMOptec International, Inc. | 3,000 | $224K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.